Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: Evidence from metabolites identified in serum
- 1 August 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (8) , 991-1001
- https://doi.org/10.1016/0277-5379(86)90067-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Method for the determination of 4′-deoxydoxorubicin, 4′-deoxydoxorubicinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Acute doxorubicin toxicity relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemiaCancer, 1984
- Determination of adriamycin, adriamycinol and their 7-deoxy aglycones in human serum by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Pharmacokinetics of adriamycin in patients with breast cancer: Correlation between pharmacokinetic parameters and clinical short-term responseEuropean Journal of Cancer and Clinical Oncology, 1982
- Efficacy and cost of cardiac monitoring in patients receiving doxorubicinCancer, 1982
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Adriamycin cardiomyopathy—risk factorsCancer, 1977
- Combination chemotherapy with adriamycin and streptozotocin; II. Clinicopharmacologic correlation of augmented adriamycin toxicity caused by streptozotocinClinical Pharmacology & Therapeutics, 1976
- AdriamycinAnnals of Internal Medicine, 1974
- Daunomycin. I. The Structure of DaunomycinoneJournal of the American Chemical Society, 1964